How psychedelics work April 6, 2025 No Comments Photo by Dima Pechurin on Unsplash Psychedelics, also known as hallucinogens, are a class of psychoactive substances that alter perception, mood and cognitive Read More »
Awakn to improve substance use and mental health disorder therapies with new collaboration April 6, 2025 No Comments Awakn Life Sciences has entered into a new collaboration with Graft Polymer to advance its New Chemical Entity (NCE) programme, Read More »
Dosing begins in 5-MeO-DMT trial for resistant depression April 6, 2025 No Comments Beckley Psytech has confirmed it has dosed the first patient in its international Phase 2b study of BPL-003 – a Read More »
UK advisory body issues rapid response on psychedelics for PTSD April 6, 2025 No Comments The UK’s independent Parliamentary Office of Science and Technology (POST) has issued a rapid response on psychedelic-assisted therapy for post Read More »
UK funds trial exploring ketamine for alcohol addiction April 6, 2025 No Comments Awakn Life Sciences has announced that its Phase III clinical trial exploring the use of ketamine-assisted therapy for the treatment Read More »
Access to MDMA-Assisted Therapy April 6, 2025 No Comments Last month, the Dutch State Commission on MDMA released its report advising the Government to allow access to MDMA-Assisted Therapy Read More »